Detalhe da pesquisa
1.
Efficacy and safety of tixagevimab/cilgavimab as passive immunisation against COVID-19 infections in patients with hematological malignancies.
Ann Hematol
; 103(6): 2123-2131, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38436671
2.
Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant-ineligible patients with newly diagnosed multiple myeloma.
Am J Hematol
; 99(5): 1008-1011, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38425185
3.
Amp(1q) and tetraploidy are commonly acquired chromosomal abnormalities in relapsed multiple myeloma.
Eur J Haematol
; 110(3): 296-304, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36433728
4.
Clonal dynamics in a composite chronic lymphocytic leukemia and hairy cell leukemia-variant.
Genes Chromosomes Cancer
; 60(4): 287-292, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33277788
5.
The prognostic value of additional copies of 1q21 in multiple myeloma depends on the primary genetic event.
Am J Hematol
; 95(12): 1562-1571, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32936982
6.
Lessons learned from immunoadsorption for hyperviscosity in IgM multiple myeloma-A case report.
J Clin Apher
; 35(3): 227-230, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32142176
7.
Ixazomib-Thalidomide-Dexamethasone for induction therapy followed by Ixazomib maintenance treatment in patients with relapsed/refractory multiple myeloma.
Br J Cancer
; 121(9): 751-757, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31558804
8.
Robo 4 - the double-edged sword in prostate cancer: impact on cancer cell aggressiveness and tumor vasculature.
Int J Med Sci
; 16(1): 115-124, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30662335
9.
Symmetric bilateral liposarcoma in an interventional cardiologist.
Lancet Oncol
; 22(4): e173, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33794213
10.
The Aplidin analogs PM01215 and PM02781 inhibit angiogenesis in vitro and in vivo.
BMC Cancer
; 15: 738, 2015 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26483043
11.
New antiangiogenic strategies beyond inhibition of vascular endothelial growth factor with special focus on axon guidance molecules.
Oncology
; 86(1): 46-52, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24401553
12.
Polyarteritis nodosa complicating multiple myeloma - a case report and review of the literature.
Clin Neuropathol
; 33(2): 143-51, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24220008
13.
"Idiopathic Bence-Jones proteinuria": a new characterization of an old entity.
Ann Hematol
; 92(9): 1263-70, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23580149
14.
Poor Mobilizers in Lymphoma but Not Myeloma Patients Had Significantly Poorer Progression-Free Survival after Autologous Stem Cell Transplantation: Results of a Large Retrospective, Single-Center Observational Study.
Cancers (Basel)
; 15(3)2023 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765566
15.
Selinexor-Based Triplet Regimens in Patients With Multiple Myeloma Previously Treated With Anti-CD38 Monoclonal Antibodies.
Clin Lymphoma Myeloma Leuk
; 23(9): e286-e296.e4, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37393120
16.
Autologous and Allogeneic Stem Cell Transplantation as Salvage Treatment Options for Relapsed/Refractory Multiple Myeloma: A Single-center Experience over 20 Years.
Anticancer Res
; 42(12): 5825-5832, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36456157
17.
GRP-78 secreted by tumor cells blocks the antiangiogenic activity of bortezomib.
Blood
; 114(18): 3960-7, 2009 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-19713465
18.
Feasibility and toxicity of concomitant radio/immunotherapy with MabThera (Rituximab®) for patients with non-Hodkin's Lymphoma: results of a prospective phase I/II study.
Strahlenther Onkol
; 187(5): 300-5, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21544528
19.
Increased levels of NETosis in myeloproliferative neoplasms are not linked to thrombotic events.
Blood Adv
; 5(18): 3515-3527, 2021 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34464975
20.
Sustained Complete Remission in Multi-Relapsed Primary CNS Lymphoma Treated with Ibrutinib Monotherapy: A Case Report.
Case Rep Oncol
; 14(3): 1337-1341, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34720938